ARID1A c.5135dup ;(p.L1712Ffs*15)

Variant ID: 1-27105522-G-GT

NM_006015.4(ARID1A):c.5135dup;(p.L1712Ffs*15)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell-derived explants.

Jci Insight
Tayoun, Tala T; Faugeroux, Vincent V; Oulhen, Marianne M; Déas, Olivier O; Michels, Judith J; Brulle-Soumare, Laura L; Cairo, Stefano S; Scoazec, Jean-Yves JY; Marty, Virginie V; Aberlenc, Agathe A; Planchard, David D; Remon, Jordi J; Ponce, Santiago S; Besse, Benjamin B; Kannouche, Patricia L PL; Judde, Jean-Gabriel JG; Pawlikowska, Patrycja P; Farace, Françoise F
Publication Date: 2022-06-08

Variant appearance in text: ARID1A: 5135dupT; Leu1712PhefsTer15
PubMed Link: 35511434
Variant Present in the following documents:
  • jciinsight-7-155804-s145.xlsx, sheet 2
  • jciinsight-7-155804-s145.xlsx, sheet 3
View BVdb publication page



Immune Checkpoint Inhibitor Therapy Achieved Complete Response for Drug-Sensitive EGFR/ALK Mutation-Negative Metastatic Pulmonary Large-Cell Neuroendocrine Carcinoma with High Tumor Mutation Burden: A Case Report.

Oncotargets And Therapy
Zhang, Xin X; Sun, Yanbin Y; Miao, Yuan Y; Xu, Shun S
Publication Date: 2020

Variant appearance in text: ARID1A: 5133_5134insT
PubMed Link: 32884302
Variant Present in the following documents:
  • Main text
  • ott-13-8245.pdf
View BVdb publication page